Cargando…
Long-Term Outcomes of the PRESERFLO MicroShunt Implant in a Heterogeneous Glaucoma Cohort
The Preserflo MicroShunt represents a novel glaucoma treatment device, necessitating long-term follow-up data to accurately assess its efficacy. The aim of this study is to report real-world data of a heterogenous glaucoma cohort who received Preserflo implantation at a specialized glaucoma clinic....
Autores principales: | Storp, Jens Julian, Vietmeier, Friederike Elisabeth, Merté, Ralph-Laurent, Koch, Raphael, Zimmermann, Julian Alexander, Eter, Nicole, Brücher, Viktoria Constanze |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342323/ https://www.ncbi.nlm.nih.gov/pubmed/37445509 http://dx.doi.org/10.3390/jcm12134474 |
Ejemplares similares
-
PreserFlo™ MicroShunt Combined with Phacoemulsification versus PreserFlo™ MicroShunt as a Standalone Procedure in Patients with Medically Resistant Open-Angle Glaucoma
por: Fili, Sofia, et al.
Publicado: (2022) -
Position of the ISTENT Inject(®) Trabecular Micro-Bypass System Visualized with the NIDEK GS-1 Gonioscope—A Postoperative Analysis
por: Zimmermann, Julian Alexander, et al.
Publicado: (2023) -
PreserFlo(®) MicroShunt: An Overview of This Minimally Invasive Device for Open-Angle Glaucoma
por: Gambini, Gloria, et al.
Publicado: (2022) -
Preliminary results of Preserflo Microshunt versus Preserflo Microshunt and Ologen implantation
por: Vastardis, Iraklis, et al.
Publicado: (2021) -
Evaluation of the Ultrastructural and In Vitro Flow Properties of the PRESERFLO MicroShunt
por: Barberá, Marta Ibarz, et al.
Publicado: (2021)